Business

Announcement on Voluntary Disclosure of Notice of Acceptance for Drug Clinical Trial Application Obtained by the Company's SSGJ-627 Injection

Announcement on Voluntary Disclosure of Notice of Acceptance for Drug Clinical Trial Application Obtained by the Company's SSGJ-627 Injection

articleSunshine Guojian Pharmaceutical (shanghai) Co., Ltd. Class AJanuary 9, 20254/news/announcement-on-voluntary-disclosure-of-notice-of-acceptance-for-drug-clinical-trial-application-obtained-by-the-companys-ssgj-627-injection
Announcement on Voluntary Disclosure of Notice of Acceptance for Drug Clinical Trial Application Obtained by the Company's SSGJ-627 Injection

About this update from Sunshine Guojian Pharmaceutical (shanghai) Co., Ltd. Class A

Announcement on Voluntary Disclosure of Notice of Acceptance for Drug Clinical Trial Application Obtained by the Company's SSGJ-627 InjectionThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Sunshine Guojian Pharmaceutical (shanghai) Co., Ltd. Class A